阿斯特拉加勒斯通过RORγt调节通过调解ILC3通过RORγt扩散来调节败血症期间的肠道免疫反应
1Emergency Department of the Second Affiliated Hospital of Nanchang University, Nanchang, China.
Heliyon
|August 4, 2023
概括
在败血症模型中,阿斯特拉加卢斯治疗减少了淋巴细胞亡,并增加了3型先天性淋巴细胞 (ILC3). 这种草药通过RORγt促进ILC3的产生,改善肠道炎症环境和生存率.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 败血症是一种危及生命的疾病,死亡率高.
- 阿斯特拉加卢斯具有已知的免疫调节和抗炎性质.
- 阿斯特拉加勒斯在败血症期间对肠道天生的免疫力的影响仍然未被探索.
研究的目的:
- 在毒症的小鼠模型中研究草对肠道先天免疫功能的影响.
- 阐明阿斯特拉加勒斯在缓解败血症引起的肠道损伤方面的潜在机制.
主要方法:
- 采用大鼠结和穿孔模型来诱导败血症.
- 评估了阿斯特拉加勒斯治疗对皮耶斑块 (PP) 和3型先天性淋巴细胞 (ILC3) 中淋巴细胞亡的影响.
- 实验室培养ILC3被用于探索阿斯特拉加勒斯的机械作用.
主要成果:
- 败血症显著增加了淋巴细胞亡,并降低了PP中的ILC3数量,加剧了肠道损伤.
- 阿斯特拉加勒斯治疗逆转了这些效应,减少了亡并增加了ILC3计数.
- 阿斯特拉加勒斯通过与视网膜酸相关的孤儿受体γt (RORγt) 促进了关键细胞因子 (IL-17A,IL-17F,IL-22,IFN-γ,GM-CSF) 的表达和ILC3的增殖.
结论:
- 阿斯特拉加勒斯有效地改善了败血症中的肠道炎症损伤.
- 这种草药通过RORγt通路促进ILC3的生成.
- 阿斯特拉加勒斯通过调节肠道天生的免疫力来证明败血症的治疗潜力.
相关概念视频
Renewal of Intestinal Stem Cells
2.6K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K


